Innsbruck'da Falk Sempozyumu
"Gut-Liver Interactions: Basic and Clinical Concepts" başlıklı 146. Falk Sempozyumu 11 - 12 Mart 2005 tarihlerinde Avusturya'nın Innsbruck kentinde yapılacak.
Sempozyumun bir günü İBH ile ilgili konulara ayrılmış.
Friday, March 11, 2005
8.00 Welcome and Introduction H. Tilg, Innsbruck
Genetics and Immunology in Inflammatory Bowel Diseases (IBD)
Chair: D. Rachmilewitz, Jerusalem; M. Zeitz, Berlin
8.10 IBD genotypes and phenotypes J.F. Colombel, Lille
8.40 The role of cytokines in the pathogenesis of experimental and human inflammatory diseases of the mucosal immune system W. Strober,Bethesda
9.10 Dendritic cells: Key players in IBD A. Kaser, Boston
9.40 Lipids and IBD: Microsomal triglyceride transfer protein – the new dimension? R. Blumberg,Boston
10.10 Epithelial cells and their role in IBD D. Podolsky, Boston
10.40 Coffee break and poster session
Evidence-based treatment in IBD
Chair: U.R. Fölsch, Kiel; A. Gangl, Vienna
11.00 Evidence-based therapy of IBD with aminosalicylates W. Reinisch, Vienna
11.30 Practical use of steroids in IBD G. D’Haens, Leuven
12.00 Immunosuppressants: Clinical use and mechanisms of action. M. Neurath, Mainz
12.30 Biologicals: Old and new ones. P. Rutgeerts, Leuven
13.00 Lunch break and poster session
Difficult cases in Inflammatory Bowel Diseases (IBD)
Chair: P. Knoflach, Wels; W. Kruis, Cologne
14.00 Case presentation Ulcerative Colitis (UC) (Discussion together with W. Petritsch, Graz) H. Lochs, Berlin
14.30 Case presentation Crohn’s Disease (CD) (and Surgery) (Discussion together with V. Annese, S. Giovanni Rotondo) S. Schreiber, Kiel
15.00 Management of perianal and fistulizing disease B.G. Feagan, London
15.30 Extraintestinal diseases J. Schölmerich, Regensburg
16.00 Coffee break and poster session
Innate Immunity – Microbial Products
Chair: R.S. Blumberg, Boston; S. Schreiber, Kiel
16.30 Good bugs and clinical use of probiotics in the treatment of IBD F. Shanahan, Cork
17.00 Immunomodulatory properties of the gut microflora R.B. Sartor, Chapel Hill
17.30 Defensis and other antibacterial mediators C. Bevins, Davis
18.00 Functional consequences of mutations in pattern recognition receptors G. Nunez, Ann Arbor
Chair: J.-F. Colombel, Paris
18.30 State-of-the-Art-Lecture:
Postinfectious irritable bowel syndrome: role of inflammation and gut flora. R. Spiller, Nottingham
19.00 End of afternoon session
Sempozyum ile ilgili tüm bilgilere http://www.falkfoundation.com adresinden ulaşabilirsiniz.
Sempozyumun bir günü İBH ile ilgili konulara ayrılmış.
Friday, March 11, 2005
8.00 Welcome and Introduction H. Tilg, Innsbruck
Genetics and Immunology in Inflammatory Bowel Diseases (IBD)
Chair: D. Rachmilewitz, Jerusalem; M. Zeitz, Berlin
8.10 IBD genotypes and phenotypes J.F. Colombel, Lille
8.40 The role of cytokines in the pathogenesis of experimental and human inflammatory diseases of the mucosal immune system W. Strober,Bethesda
9.10 Dendritic cells: Key players in IBD A. Kaser, Boston
9.40 Lipids and IBD: Microsomal triglyceride transfer protein – the new dimension? R. Blumberg,Boston
10.10 Epithelial cells and their role in IBD D. Podolsky, Boston
10.40 Coffee break and poster session
Evidence-based treatment in IBD
Chair: U.R. Fölsch, Kiel; A. Gangl, Vienna
11.00 Evidence-based therapy of IBD with aminosalicylates W. Reinisch, Vienna
11.30 Practical use of steroids in IBD G. D’Haens, Leuven
12.00 Immunosuppressants: Clinical use and mechanisms of action. M. Neurath, Mainz
12.30 Biologicals: Old and new ones. P. Rutgeerts, Leuven
13.00 Lunch break and poster session
Difficult cases in Inflammatory Bowel Diseases (IBD)
Chair: P. Knoflach, Wels; W. Kruis, Cologne
14.00 Case presentation Ulcerative Colitis (UC) (Discussion together with W. Petritsch, Graz) H. Lochs, Berlin
14.30 Case presentation Crohn’s Disease (CD) (and Surgery) (Discussion together with V. Annese, S. Giovanni Rotondo) S. Schreiber, Kiel
15.00 Management of perianal and fistulizing disease B.G. Feagan, London
15.30 Extraintestinal diseases J. Schölmerich, Regensburg
16.00 Coffee break and poster session
Innate Immunity – Microbial Products
Chair: R.S. Blumberg, Boston; S. Schreiber, Kiel
16.30 Good bugs and clinical use of probiotics in the treatment of IBD F. Shanahan, Cork
17.00 Immunomodulatory properties of the gut microflora R.B. Sartor, Chapel Hill
17.30 Defensis and other antibacterial mediators C. Bevins, Davis
18.00 Functional consequences of mutations in pattern recognition receptors G. Nunez, Ann Arbor
Chair: J.-F. Colombel, Paris
18.30 State-of-the-Art-Lecture:
Postinfectious irritable bowel syndrome: role of inflammation and gut flora. R. Spiller, Nottingham
19.00 End of afternoon session
Sempozyum ile ilgili tüm bilgilere http://www.falkfoundation.com adresinden ulaşabilirsiniz.
